Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Skin Diseases × Everolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 5 Neoplasms 3 Tuberous Sclerosis 2 Neuroendocrine Tumors 2 Kidney Neoplasms 2 Breast Neoplasms 2 Angiomyolipoma 2 Waldenstrom Macroglobulinemia 1 Skin Neoplasms 1 Skin Diseases 1 Pancreatic Neuroendocrine Tumors 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Lymphoma 1 Lymphangioleiomyomatosis 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Carcinoid Tumor 1 Breast Diseases 1

Interventions

methyl 5-aminolevulinate 1 exemestane 1 Sodium Chloride 1 Everolimus 1 Botulinum Toxins, Type A 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01743560 2019-07-18

4EVERUK

Novartis

Phase 4 Completed

52 enrolled 16 charts

Breast Diseases, Breast Neoplasms, Neoplasms, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡